Family Medicine · New London, CT
NPI
1558437269
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
435 Montauk Ave
New London, CT, 06320
Phone (860) 444-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,333 services
Medicare patients, 2024
201
Average age 67
Drug cost, 2024
$2.9M
14,977 prescriptions
Company payments, 2025
$5,277
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Helar E Campos was code 99214 (office e&m - established), 584 times for 173 patients. In total Helar E Campos billed 1,333 services in 14 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 584 | 173 | $89.64 | $52K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 507 | 71 | $46.67 | $24K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 195 | 57 | $37.71 | $7,354 |
| 99213 Office E&M - Established | Office | 15 | 14 | $74.89 | $1,123 |
By year: 2022 $148K for 2,362 services; 2023 $126K for 1,831 services; 2024 $88K for 1,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Helar E Campos prescribed most often to Medicare patients was Rosuvastatin Calcium, with 688 prescriptions and refills. In total Helar E Campos wrote 14,977 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 688 | 1,850 | 221 | $9,696 |
| Amlodipine Besylate Generic | 468 | 1,265 | 151 | $2,191 |
| Metformin Hcl Generic | 454 | 1,056 | 123 | $2,577 |
| Atorvastatin Calcium Generic | 452 | 1,107 | 126 | $3,497 |
| Losartan Potassium Generic | 369 | 985 | 105 | $1,921 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 361 | 435 | 86 | $277K |
| Lisinopril Generic | 340 | 918 | 111 | $1,490 |
| Levothyroxine Sodium Generic | 323 | 783 | 90 | $3,768 |
| Tamsulosin Hcl Generic | 307 | 698 | 80 | $2,767 |
| Montelukast Sodium Generic | 282 | 560 | 75 | $2,255 |
| Gabapentin Generic | 275 | 373 | 62 | $3,735 |
| Tradjenta Linagliptin | 269 | 567 | 68 | $285K |
| Pantoprazole Sodium Generic | 266 | 577 | 82 | $2,493 |
| Omeprazole Generic | 241 | 577 | 71 | $4,098 |
| Ozempic Semaglutide | 228 | 274 | 39 | $227K |
Brand drugs: 3,604 claims; generic drugs: 11,254 claims; opioid claims: 411.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Helar E Campos $5,277 ($5,277 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $805.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 49 | $805 |
| Phathom Pharmaceuticals, Inc. PHAT | 24 | $581 |
| Novo Nordisk Inc NVO | 15 | $402 |
| GlaxoSmithKline, LLC. GSK | 19 | $395 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $329 |
| Axsome Therapeutics, Inc. AXSM | 11 | $275 |
| Vanda Pharmaceuticals Inc. VNDA | 12 | $266 |
| Lilly USA, LLC LLY | 8 | $258 |
| Dexcom, Inc. DXCM | 21 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $233 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.